University Hospital, Clermont-Ferrand: Neoplasms trials

The registry lists 11 Neoplasms studies with University Hospital, Clermont-Ferrand as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 3Phase 3 1Phase 4 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell CarcinomaRecruitingNCT07205731Phase 2
• Vulnerability and Risk of Neuropathic Pain in CancerRecruitingNCT06511674Not applicable
• Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)RecruitingNCT04673981Not applicable
• Exploration of the Relationship Between Sexual Health and Pain in the Context of Cancer in FranceCompletedNCT06508411
• The Experience of the Child With Cancer When Port à Cath Needle : Child's SpeechCompletedNCT05691816
• Exploration of Patient Self-medication Practices During and After Cancer in FranceCompletedNCT05156931
• Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ?CompletedNCT04487639Not applicable
• Early Palliative Care for Patients With Haematological MalignanciesStatus unknownNCT03800095Phase 3
• Comparison of the Ultra-low-dose Veo Algorithm With the Gold Standard Filtered Back Projection for Detecting Pulmonary Asbestos-related ConditionsCompletedNCT01955018Phase 4
• Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)Status unknownNCT00751894Phase 2
• Evaluation of Pegfilgrastim for Stem Cell Mobilization in ChildrenTerminatedNCT00695370Phase 2